forming a long triangle?working on an immunopass covid test, info is saying final phase, is this a good sign, i am a beginner.
0%
0%
0%
0%
0%
−0.0458USD
−6.243MUSD
8.875KUSD
233.649M
About Axim Biotechnologies, Inc.
Sector
CEO
John W. Huemoeller
Headquarters
San Diego
Website
Employees
9
Founded
2010
ISIN
US05463V1008
AXIM Biotechnologies, Inc. operates as a biotechnology company, which engages in the development of diagnostic healthcare solutions. Its product categories include Eye Health, SARS-CoV-2, and fentanyl neutralizing antibody test. The company was founded on November 18, 2010 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
